soul trial semaglutide (NEJM 2025): Oral led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular

doi:10.1507/endocrj.EJ12-0158 162

The pre-filled pen is designed for simple subcutaneous administration and should be used only according to your healthcare providers instructions

Dietary fat-associated osteoarthritic chondrocytes gain resistance to lipotoxicity through PKCK2/STAMP2/FSP27

If treading lightly on our earth matters to you, youll love our huge range of healthy living and wellness products: Natural Health featuring best-selling magnesium and gut health support Beauty & Body from your favourite natural skincare and clean makeup Food & Drink including collagen and protein powders Family Wellness to support your pregnancy journey and baby & kids health Eco-Living packed with essential oils, zero waste and much more All curated with you and our planet in mind

Can you send me the coverage policy in writing?" WHAT TO EXPECT BY PLAN TYPE Anthem's 2025 Zepbound Coverage Here's the realistic coverage landscape for Anthem members in 2025: Coverage by Plan Type and Region 2025 GLP-1 Coverage Rollbacks Major Coverage Changes in 2025-2026 Several Blue Cross/Blue Shield plans (including Anthem affiliates) are tightening or eliminating GLP-1 weight loss coverage due to cost concerns: California Medi-Cal (Anthem): Ended all GLP-1 weight loss coverage on 1/1/2026

Cross-disease analysis of Alzheimers disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases